Discover 2,271 paid clinical trials in Oakland, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,271
Active & Responsive
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
for
Turner Syndrome, Short Stature Homeobox Gene Mutation,
Location: Palo Alto CA, Sacramento CA, Idaho Falls ID, Seattle WA,
Sponsor: Ascendis Pharma A/S
Sex: All
Age: 2 - 17
Code: NCT07221851
Phase3, Recruiting
Active & Responsive
Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors
for
Solid Tumor
Location: Stanford CA, Santa Monica CA, El Segundo CA,
Sponsor: Alyssum Therapeutics
Sex: All
Age: 18+
Code: NCT06234098
Phase1, Phase2, Recruiting
Active & Responsive
Methods of Identifying Effective Off-Guideline Treatments for Advanced Cancer Patients (CC N-of-1)
for
Advanced Cancer
Location: Palo Alto CA
Sponsor: Cancer Commons
Sex: All
Age: 18+
Code: NCT07343024
Recruiting
Active & Responsive
ALXN2350 in Adult Participants With BAG3-Associated Dilated Cardiomyopathy
for
BAG3 Mutation Associated Dilated Cardiomyopathy
Location: Palo Alto CA, Portland OR, Houston TX, Birmingham AL,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18 - 70
Code: NCT07218887
Phase1, Phase2, Recruiting
Active & Responsive
FACE Phase II (a Stage II Trial)
for
MCI, Subjective Cognitive Decline (SCD),
Location: Palo Alto CA
Sponsor: Stanford University
Sex: All
Age: 60 - 70+
Code: NCT07130669
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)
for
Alcohol Use Disorder
Location: Palo Alto CA, West Los Angeles CA, Long Beach CA,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18 - 70+
Code: NCT07218354
Phase3, Recruiting
Active & Responsive
Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response
for
Chronic Low Back Pain
Location: Palo Alto CA, Long Beach CA, Loma Linda CA, Portland OR,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT04142177
Recruiting
Active & ResponsiveNew
Repetitive Transcranial Magnetic Stimulation Treatment of Stimulant Use Disorder
for
Stimulant Use Disorder
Location: Palo Alto CA
Sponsor: VA Office of Research and Development
Sex: All
Age: 18 - 65
Code: NCT07112105
Recruiting
Active & Responsive
Detection of EEG-Based Biomarkers of Chronic Low Back Pain
for
Chronic Low-back Pain, Healthy
Location: Palo Alto CA
Sponsor: Stanford University
Sex: All
Age: 18 - 70+
Code: NCT06025201
Recruiting
Active & Responsive
Interventions in Mathematics and Cognitive Skills
for
Math Learning Disability, Child Development,
Location: Palo Alto CA
Sponsor: Stanford University
Sex: All
Age: 6 - 12
Code: NCT05201534
Recruiting
Active & Responsive
FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
for
Alpha-Thalassemia, Beta-Thalassemia, Amyloidosis,
Location: Los Altos CA
Sponsor: xCures
Sex: All
Age: 0+
Code: NCT06539169
Recruiting
Active & Responsive
A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
for
Solid Tumor
Location: Palo Alto CA, Duarte CA, La Jolla CA,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18+
Code: NCT06384807
Phase1, Phase2, Recruiting
Active & Responsive
A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)
for
Amyotrophic Lateral Sclerosis
Location: Palo Alto CA, La Jolla CA, Columbia MO, Columbus OH,
Sponsor: Insmed Gene Therapy LLC
Sex: All
Age: 18 - 70+
Code: NCT07290062
Phase1, Recruiting
Active & Responsive
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)